Related Experiment Videos
[Antisense human telomerase reverse transcriptase inhibits leukemia cell proliferation in vitro]
Lai-bao Sun1, Cheng-rong Li, Jian-ming Wen
1Shenzhen Children's Hospital, Shenzhen 518026, China. sunlb163@hotmail.com
Di 1 Jun Yi Da Xue Xue Bao = Academic Journal of the First Medical College of PLA
|May 21, 2004
Summary
Antisense human telomerase reverse transcriptase (hTERT) effectively inhibits leukemia cell growth and proliferation in vitro. This targeted therapy works by reducing hTERT mRNA and telomerase activity, potentially inducing apoptosis.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Context:
- Leukemia is characterized by uncontrolled cell proliferation.
- Human telomerase reverse transcriptase (hTERT) is crucial for maintaining telomere length and is often overexpressed in cancer cells, including leukemia.
- Targeting hTERT offers a potential strategy for leukemia treatment.
Purpose:
- To investigate the inhibitory effect of antisense hTERT on leukemia cell proliferation in vitro.
- To assess the impact of antisense hTERT on hTERT mRNA expression and telomerase activity.
- To determine the mechanism by which antisense hTERT affects leukemia cell growth and survival.
Summary:
- Antisense hTERT expression vectors were introduced into the HL(60) leukemia cell line.
- Quantitative real-time RT-PCR and telomerase assays confirmed reduced hTERT mRNA and activity.
- Proliferation assays (MTT, soft agar) and flow cytometry demonstrated significantly decreased proliferation and increased apoptosis in HL(60)-as cells compared to controls.
Impact:
- Antisense hTERT demonstrates significant potential as a molecular biotherapy for leukemia.
- Down-regulation of hTERT and telomerase activity by antisense hTERT effectively inhibits leukemia cell growth.
- The findings suggest that apoptosis is a key mechanism mediating the anti-leukemic effects of hTERT-targeted therapy.